Clinical Trial Update: Focal Electrically-Administered Seizure Therapy (FEAST) Studies at Two Enrolling Sites to Further Test and Refine the Treatment [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 FEAST trial updates completed at two sites evaluating Focal Electrically-Administered Seizure Therapy for depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Focal Electrically-Administered Seizure Therapy (null)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Depression | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-02-04